HIV& AIDS

Zimbabwe has a generalized heterosexually-driven HIV epidemic with adult prevalence of 15 per cent (ZDHS 2010/2011) and an annual incidence of 0.98 per cent (National HIV and AIDS Estimates Report 2013). The country has an estimated 1.4 million people living with HIV, with the third largest HIV burden in Southern Africa after South Africa and Mozambique.

Prevalence has nearly halved since the epidemic’s peak in 1997 when it stood at 28 per cent.  HIV prevalence among women aged 15 to 24 is 1.5 times higher than men of the same age (MICS 2014).

Fast-tracking efforts to end the AIDS epidemic in Zimbabwe is possible by working together to:  foster innovation, secure sustainable financing, strengthen health systems and communities, ensure commodity security, promote human rights and gender equality, and ensure access to HIV prevention and treatment services.

During the period of 2016 to 2020, the UN will contribute to the following outcomes:

  1. All adults and children have increased HIV knowledge, use effective HIV prevention services, and are empowered to participate in inclusive and equitable social mobilization to address drivers of the epidemic

  2. 90% of all people living with HIV know their HIV status, at least 90% of HIV positive people receive sustained antiretroviral therapy, 90% of those on treatment have durable viral load suppression

  3. Key institutions from Government and civil society effectively and efficiently manage a multi-sectoral AIDS response

It is also linked to the Sustainable Development Goals, particularly Goal 3 on healthy lives and its sub-goal to end the epidemics of AIDS, tuberculosis, malaria, and neglected tropical diseases and combat hepatitis, water-borne diseases, and other communicable diseases by 2030. In addition, these outcomes will contribute to the SDGs related to equality, dignity, inclusion and development.

The Government of Zimbabwe, the UN and other partners continue to mobilise resources from both domestic and international sources to support the national HIV response.

Resources required to achieve this result area are USD 260 million.